{"title":"Response to \"Considering the Potential Benefits of Over-the-Counter Naloxone\" by Evoy et al [Letter].","authors":"Brian Fuehrlein","doi":"10.2147/IPRP.S324498","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":45655,"journal":{"name":"Integrated Pharmacy Research and Practice","volume":"10 ","pages":"75-76"},"PeriodicalIF":2.1000,"publicationDate":"2021-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/25/41/iprp-10-75.PMC8256108.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Integrated Pharmacy Research and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/IPRP.S324498","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}